Details of the Drug
General Information of Drug (ID: DM15CJZ)
Drug Name |
UCL-2138
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
UCL-2138; CHEMBL129257; 4-(3-piperidin-1-ylpropoxy)benzonitrile; Benzonitrile, 4-[3-(1-piperidinyl)propoxy]-; 146440-20-2; AC1MGZLJ; ACMC-20n4tz; SCHEMBL491825; GTPL1257; CTK0B2418; DTXSID60388154; UCL2138; ZINC2009079; UCL 2138; PDSP2_000689; BDBM50133003; PDSP1_000699; AKOS009440882; MCULE-6416627117; 4-[3-(1-Piperidinyl)propoxy]benzonitrile; 4-(3-Piperidin-1-yl-propoxy)-benzonitrile; 4-(3-(piperidin-1-yl)propoxy)benzonitrile
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 244.33 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.9 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 5 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References